Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Iowa for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Iowa only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Iowa (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Michael Wadzinski (NPI 1982674297)

Field	Value
Entity Type	Individual
Organization	Michael Wadzinski
Address	5855 Sunnybrook Dr.
City	Sioux City
State	IA
ZIP	51106
Taxonomy	Ophthalmology Physician
NPI Enumerated	January 26, 2006

Payer Source	Total Paid
Medicare	$4.8M
Medicaid	$0

Key Findings

This provider's lifetime Medicare footprint is $4.8M in Medicare revenue and no Medicaid billing is on file, making the practice effectively single‑payer (Medicare) in the dataset. The absence of any Medicaid claims suggests limited exposure to Medicaid patient volume and price schedules and concentrated reliance on Medicare reimbursement for revenue stability.

Revenue is highly concentrated in a small set of procedure/drug codes: the precomputed top three Medicare codes account for 86.3% of this provider's total Medicare revenue. Those top-three contributors are J0178 ($2.2M, 46.3%), J2777 ($1.6M, 34.0%), and 67028 ($290.5K, 6.1%), indicating dependence on intravitreal drug administration and related ocular injection procedures for the bulk of income.

Code-level volumes underline a procedural, retina-focused practice: J0178 shows 3.2K claims and J2777 shows 55.9K claims, while 67028 has 3.2K claims and 92134 (retinal imaging) has 3.8K claims. This mix — high-volume injectable biologics combined with thousands of diagnostic retinal imaging claims — is consistent with a practice centered on medical retina services rather than general comprehensive ophthalmology.

Competitive standing versus national Medicare peers is strong for core procedure codes. J0178 ranks #141 of 3204 providers (96th percentile; notably above typical national volume), J2777 ranks #81 of 2039 providers (96th percentile; notably above typical national volume), and 67028 ranks #82 of 4255 providers (98th percentile; extreme outlier), while 92134 ranks #163 of 26868 providers (99th percentile; extreme outlier), together signaling that this provider is a major national contributor for intravitreal injections and retinal imaging.

The practice generates comparatively modest office evaluation-and-management revenue relative to procedural/drug billing: 99214 appears with 647 claims and $58.9K revenue (1.2% of Medicare revenue) and other E/M codes (e.g., 99213, 99212) are each only a small share of revenue. This imbalance suggests a workflow and revenue model that prioritize in-office procedures and drug administration over traditional office visits.

Several codes are flagged as statistical outliers or notably above typical volumes in national comparisons, reinforcing the procedural concentration. Specifically, 67028 and 92134 are described as "extreme outlier" (98th and 99th percentiles respectively), while J0178, J2777, and J3590 are "notably above typical national volume," indicating unusually high procedural and injectable biologic activity relative to peers.

The provider utilizes multiple anti‑VEGF and related agents, including aflibercept (J0178, $2.2M), faricimab (J2777, $1.6M), and a ranibizumab biosimilar (Q5124, $216.7K, 4.5%), showing diversification across branded and biosimilar intravitreal therapies. This product mix implies sensitivity to changes in Medicare drug reimbursement and utilization patterns for high-cost ophthalmic biologics.

This NPI has been enumerated since 2006-01-26 (≈20 years ago), indicating an established practice with sustained Medicare activity over two decades. Longevity paired with consistently high national ranks on core procedural and imaging codes suggests an entrenched specialty role in the medical retina space rather than a recent or sporadic billing pattern.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

25 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	3,220	$690	$2.2M
J2777	Injection, faricimab‑svoa, 0.1 mg	55,870	$30	$1.6M
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	3,160	$90	$290.5K
Q5124	Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg	1,260	$170	$216.7K
J3590	Unclassified biologics	730	$180	$129.4K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	3,790	$30	$113.7K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	650	$90	$58.9K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	290	$120	$35.3K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	220	$150	$33.2K
67108	The provider repairs a detached retina using heat produced by a laser beam or by freezing the tissues. He may attach a scleral buckle to simplify the passage of fluid through and behind the retina or…	10	$890	$10.7K

Showing 1–10 of 25

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 25 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Iowa Distribution

Michael Wadzinski — 5 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Iowa

Full comparison — all codes billed, vs. state median

25 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J2777	10	20	43,140	$30	$1.7M
J0178	4	40	640	$690	$760.2K
Q5124	1	10	740	$170	$130.5K
67028	5	60	420	$80	$80.6K
J7312	4	10	200	$160	$32.9K
J3590	4	30	140	$100	$26.7K
92014	329	500	200	$70	$19.8K
67108	16	20	20	$830	$15K
99214	299	4,690	100	$70	$14.4K
99213	4,470	4,740	100	$50	$8K

Showing 1–10 of 25

Nearby Providers

Other providers in the same ZIP code as Michael Wadzinski, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Mid-step Services, Inc.	IA	Developmentally Disabled Services Day Training Agency	$0	$51.5M
Northwest Aea 12	IA	Local Education Agency (LEA)	$0	$2.1M
Qualicenters Sioux City, LLC	IA	End-Stage Renal Disease (ESRD) Treatment Clinic/Center	$0	$1.5M
Prairie Pediatrics & Adolescent Clinic, P.C.	IA	Pediatric Cardiology Physician	$0	$1M
Daniel L Kaler Dds PC	IA	Orthodontics and Dentofacial Orthopedics Dentistry	$0	$907K
Heather Longval	IA	Family Medicine Physician	$381.1K	$0
Bryce Robison	IA	Family Medicine Physician	$267.4K	$0
Delna Lee	IA	Family Medicine Physician	$225K	$0
Michael Jennings	IA	Family Medicine Physician	$188.3K	$0
Troy Fluent	IA	Chiropractor	$34.5K	$151.7K

Michael Wadzinski — Billing Profile & Reimbursement Data

Sign up for Michael Wadzinski — Billing Profile & Reimbursement Data policy alerts

Michael Wadzinski — Billing Profile & Reimbursement Data

Sign up for Michael Wadzinski — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Nearby Providers

Frequently Asked Questions

References